137 related articles for article (PubMed ID: 6610200)
41. Effect of vardenafil, an inhibitor of phosphodiesterase-5, on portal haemodynamics in normal and cirrhotic liver -- results of a pilot study.
Deibert P; Schumacher YO; Ruecker G; Opitz OG; Blum HE; Rössle M; Kreisel W
Aliment Pharmacol Ther; 2006 Jan; 23(1):121-8. PubMed ID: 16393289
[TBL] [Abstract][Full Text] [Related]
42. Vasopressin and vasopressin plus nitroglycerin for portal hypertension. Effects on systemic and splanchnic hemodynamics and coronary blood flow.
Rector WG; Hossack KF
J Hepatol; 1989 May; 8(3):308-15. PubMed ID: 2499616
[TBL] [Abstract][Full Text] [Related]
43. Effects of histamine, vasopressin, and angiotensin II on hepatosplanchnic hemodynamics, liver function, and hepatic metabolism in cats.
Krarup N
Acta Physiol Scand; 1975 Nov; 95(3):311-7. PubMed ID: 1189938
[TBL] [Abstract][Full Text] [Related]
44. Drug therapy for portal hypertension.
Rector WG
Ann Intern Med; 1986 Jul; 105(1):96-107. PubMed ID: 2872847
[TBL] [Abstract][Full Text] [Related]
45. Effects of vaso-active agents on hepatic function and blood gases in patients with cirrhosis: a study of vasopressin and nitroglycerin.
Iwao T; Toyonaga A; Sumino M; Takagi K; Oho K; Ohkubo K; Inoue R; Tanikawa K
J Gastroenterol Hepatol; 1992; 7(2):148-53. PubMed ID: 1571496
[TBL] [Abstract][Full Text] [Related]
46. Controlled trial of vasopressin plus nitroglycerin vs. vasopressin alone in the treatment of bleeding esophageal varices.
Tsai YT; Lay CS; Lai KH; Ng WW; Yeh YS; Wang JY; Chiang TT; Lee SD; Chiang BN; Lo KJ
Hepatology; 1986; 6(3):406-9. PubMed ID: 3086203
[TBL] [Abstract][Full Text] [Related]
47. Cutaneous reaction to vasopressin.
Lemlich G; Di Grandi S; Szaniawski WK
Cutis; 1996 May; 57(5):330-2. PubMed ID: 8726714
[TBL] [Abstract][Full Text] [Related]
48. Doppler study of mesenteric, hepatic, and portal circulation in alcoholic cirrhosis: relationship between quantitative Doppler measurements and the severity of portal hypertension and hepatic failure.
Taourel P; Blanc P; Dauzat M; Chabre M; Pradel J; Gallix B; Larrey D; Bruel JM
Hepatology; 1998 Oct; 28(4):932-6. PubMed ID: 9755228
[TBL] [Abstract][Full Text] [Related]
49. Rhabdomyolysis and cutaneous necrosis following intravenous vasopressin infusion.
Moreno-Sánchez D; Casis B; Martín A; Ortiz P; Castellano G; Muñoz MT; Vanaclocha F; Solís-Herruzo JA
Gastroenterology; 1991 Aug; 101(2):529-32. PubMed ID: 2065928
[TBL] [Abstract][Full Text] [Related]
50. The responses of the hepatic and splanchnic vascular beds to vasopressin in rats.
Zhang W; Shibamoto T; Kuda Y; Shinomiya S; Kurata Y
Biomed Res; 2012 Apr; 33(2):83-8. PubMed ID: 22572382
[TBL] [Abstract][Full Text] [Related]
51. Measurement and correlation of wedged hepatic, intrahepatic, intrasplenic and intravariceal pressures in patients with cirrhosis of liver and non-cirrhotic portal fibrosis.
Sarin SK; Sethi KK; Nanda R
Gut; 1987 Mar; 28(3):260-6. PubMed ID: 3570030
[TBL] [Abstract][Full Text] [Related]
52. Action of the triglycyl hormonogen of vasopressin (glypressin) in patients with liver cirrhosis and bleeding esophageal varices.
Vosmík J; Jedlicka K; Mulder JL; Cort JH
Gastroenterology; 1977 Apr; 72(4 Pt 1):605-9. PubMed ID: 300062
[TBL] [Abstract][Full Text] [Related]
53. Intravenous vasopressin in patients with portal hypertension: advantages of continuous infusion.
Thomford NR; Sirinek KR
J Surg Res; 1975 Feb; 18(2):113-7. PubMed ID: 1134080
[No Abstract] [Full Text] [Related]
54. Circulatory actions of vasopressin in anaesthetized rats with portal hypertension subjected to haemorrhage.
Valla D; Geoffroy P; Girod C; Lebrec D
J Hepatol; 1986; 2(3):328-39. PubMed ID: 3722788
[TBL] [Abstract][Full Text] [Related]
55. Splanchnic and systemic hemodynamics in early abstinence and after ethanol administration in non-cirrhotic alcoholic patients.
Silva G; Fluxá F; Bresky G; Backhouse C; Palma M; Ruiz M; Hirsch S; Iturriaga H
J Hepatol; 1994 Apr; 20(4):494-9. PubMed ID: 8051388
[TBL] [Abstract][Full Text] [Related]
56. Effects of vasopressin and nicardipine on hemodynamics and liver function in patients with cirrhosis: comparison with vasopressin alone.
Iwao T; Toyonaga A; Ikegami M; Oho K; Sumino M; Sakaki M; Shigemori H; Nakayama M; Sasaki E; Tanikawa K
J Hepatol; 1993 Nov; 19(3):345-52. PubMed ID: 8151095
[TBL] [Abstract][Full Text] [Related]
57. Complications of cirrhosis. I. Portal hypertension.
Bosch J; García-Pagán JC
J Hepatol; 2000; 32(1 Suppl):141-56. PubMed ID: 10728801
[TBL] [Abstract][Full Text] [Related]
58. Arterial vasopressin infusions: science or seance?
Nusbaum M; Conn HO
Gastroenterology; 1975 Jul; 69(1):263-7. PubMed ID: 1097293
[No Abstract] [Full Text] [Related]
59. Effect of propofol infusion on splanchnic hemodynamics and liver oxygen consumption in the rat. A dose-response study.
Carmichael FJ; Crawford MW; Khayyam N; Saldivia V
Anesthesiology; 1993 Nov; 79(5):1051-60. PubMed ID: 8238982
[TBL] [Abstract][Full Text] [Related]
60. Emergency treatment of variceal haemorrhage.
Sagar S; Harrison ID; Brearley R; Shields R
Br J Surg; 1979 Nov; 66(11):824-6. PubMed ID: 316346
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
